Cipla
Global pharmaceutical leader
- B2B
- B2C
About Cipla
A global pharmaceutical company with a compassionate approach to healthcare, providing high-quality medicines across 80+ countries for over 85 years
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- mumbai, maharashtra, India
- Founded
- 1935
- Revenue
- $96.2M – $760MTamtam estimate
- Website
- cipla.com
- linkedin.com/company/cipla
Cipla in the news
- Cipla and 3 other fundamentally strong stocks with low debt and PE less than the industry
Four fundamentally strong companies including Cipla, with low debt and below-industry PE ratios, are highlighted as attractive long-term investments.
- Stocks in news: Jio Financial, Adani Green, Nestle, Cipla, IOC, Waaree Energies
Cipla launched a new injectable drug for obesity and type-2 diabetes amid various corporate developments in major Indian companies.
- Cipla shares rise over 1% as pharma major launches obesity, diabetes treatment drug in India
Cipla launched Yurpeak, a new injectable drug for obesity and type 2 diabetes, distributing it across India with Lilly's support.
- Cipla Launches Yurpeak in India, a Weekly Tirzepatide Injection for Obesity and Diabetes
Cipla launched Yurpeak, a weekly tirzepatide injection for obesity and type 2 diabetes in India, partnering with Eli Lilly for supply and focusing on patient support.
- Cipla debuts weight-loss drug Tirzepatide second brand Yurpeak
Cipla launched Tirzepatide as Yurpeak in India, targeting diabetes and weight management with a strong focus on expanding reach beyond Eli Lilly's market.
Cipla at a glance
Cipla is a B2B/B2C company in the Pharmaceutical Manufacturing industry, headquartered in mumbai, maharashtra, India.
Cipla was founded in 1935.
Cipla has 10,000+ employees.
Cipla's revenue is $96.2M – $760M (Tamtam estimate).
Selling to companies like Cipla?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies